Employer-Based Disease Management Programs in Cancer: Experience to Date

Disease Management and Health Outcomes

Volumn 12, Issue 1, 2004, Pages 9-17

  Lee, Frederick C ^a,b,c  

^a Quality Oncology Inc   (United States)

^b Accountable Oncology Associates   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACNE; ANEMIA; BLADDER DISEASE; BREAST CARCINOMA; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE ASSOCIATION; DRY SKIN; ECONOMIC ASPECT; FATIGUE; HAIR LOSS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH MAINTENANCE ORGANIZATION; HUMAN; IRRITABLE COLON; LEUKEMIA; LYMPHOMA; MEDICAID; MORBIDITY; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PROSTATE CARCINOMA; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 1442359899     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200412010-00002     Document Type: Review

References (50)

1. Freudenheim M. Employees pay 48% more for company health plans. New York Times 2003 Sep 11, A-1
2. Stires D. Health costs: the breaking point. Fortune 2003 Feb 18; 147 (3): 76
3. Kirsh WD, Lee R. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program. Manag Care Interface 1999; 12 (8): 65-8
4. Kessler RC. Impact of chronic health conditions on employers. J Occup Environ Med 2001; 43: 218-25
5. Ries LAG, Kosary CL, Hankey BF, et al. Seer Cancer Statistics Review, 1973-1999. Bethesda (MD): National Cancer Institute: NIH publication no. 97-2789, 2003
6. National Institutes of Health. Preventing and controlling cancer. Bethesda (MD): National Cancer Institute and Centers for Disease Control, 2003
7. Chirikos TN. Economic impact of the growing population of breast cancer survivors. Cancer Control 2001; 8 (2): 177-83
8. Harris JM. Disease management: new wine in new bottles? Ann Intern Med 1996; 124: 838-42
9. Association for Worksite Health Promotion. William M. Mercer, Inc., US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. 1999 National Worksite Health Promotion Survey: report of survey findings. Northbrook (IL): William M. Mercer. 2000
10. Hewitt Associates. Health care expectations: future strategy and direction. Lincolnshire (IL): Hewitt Associates, 2002
11. Cotter M. Why are some employers surviving the health care crunch? Bus Health 2003 May 15; 21: 21-6
12. Coye MJ. No Toyotas in health care: why medical care has not evolved to meet patients' needs. Health Aff 2001; 20: 44-56
13. Edlin M. DMAA complements plans' efforts to improve care and control costs. Managed Health Care Executive 2001; 12 (8) Jul/Aug: 34-36
14. Wheatley B. Disease management: finding from leading state programs. Academy Health Issue Brief 2002 Dec; III (3): 1-6
15. Cozma CM. Demonstration projects recognize the value of disease management. Manag Care Interface 2002 Nov; 15: 39-40
16. Berwick DM. As good as it should get: making health care better in the new millennium. Institute for Healthcare Improvement Keynote Address, 2001 Aug; Boston (MA)
17. Lee FC. Is cancer meant to be managed? Managed Care: Cancer 2001 Mar/ Apr; 14-9
18. Sanoshy JK, West PA. The impact of clinical guidelines on oncology care. Oncology Issues 2002; 17 (4): 20-6
19. Kochaniec WJ. Patients as gatekeepers: employers equipping workers to make informed choices. Bus Insur 2000 Feb 21; 1: 44
20. Penne J. MD Anderson's Cancer Manager™ signs first contracts [press release]. 1998 Nov 30
21. Dainas C, Beien L. Targeting depression: an employer's approach. Bus Health 2003 May 15; 21: 21-5
22. Fallowfield L, Ratcliffe D, Jenkins V, et al. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001 Apr 8; 84: 1011-5
23. Talan J. Chronic depression link to cancer suspected. Newsday 1998 Dec 28, A16
24. Friedman B, Devers K, Hellinger F, et al. Carve outs and related models of contracting for specialty care: framework and highlights of a workshop. Am J Manag Care 1998; 4: 11-21
25. Kerns E, Ockers N. Managing disease states: an emerging market sector [report]. Credit Suisse First Boston. New York: 2000 Feb 10
26. Lugnado L. Cancer hospitals are refusing patients seeking second opinions. Wall Street Journal 2001 May 31, 1
27. Barnett A, Birnbaum H, Cremieux, et al. The costs of cancer to a major employer in the united states: a case-control analysis. Am J Manag Care 2000; 6: 1243-51
28. Kesteloot K. Predicting the future health care expenses of cancer. Eur J Cancer 1994; 30A: 3-4
29. Diamond F. Believe it: HEDIS scores matter to employers. Managed Care Magazine 2003; 12: 27-9
30. Grove A. Taking on prostate cancer. Fortune 2001 Mar 15; 13: 78-91
31. Gaul G. Who needs to worry about prostate cancer? Men's Health 2001 Jul; 16(6): 28-34
32. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747-51
33. Galvin RS. The business case for quality. Health Aff 2001; 20: 57-8
34. Sepucha KR, Belkora J, Mutchnich S, et al. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol 2002; 20 (11): 2695-700
35. Whelan T, Sawka C, Levine M, et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 2003; 95 (8): 581-7
36. Calhoun EA, Bennett CL. Evaluating the total costs of cancer. Oncology 2003; 17: 109-14
37. Grunberg SM. Economic impact of antiemesis. Oncology 1995; 9 Suppl. 11: 155-60
38. Scheitel S. Agreement about medical diagnoses. Mayo Clin Proc 1996; 71 (12): 1131-7
39. Lee FC. Disease management in the treatment of cancer. Med Interface 1995; 8 (12): 126-31
40. Lee S. Putting shared decision makin into practice: 17 ways to improve doctor-patient communication. Hematol Oncol News and Issues 2003 Mar; 2 (3): 27-32
41. Shapiro DE, Boggs SR, Rodrigue JR, et al. Stage II breast cancer differences between four coping patterns in side effects during adjuvant chemotherapy. J Psychosom Res 1997; 43 (2): 143-57
42. Boon H, Stewart M, Kennard MA. Use of complementary/alternative medicine by breast cancer survivors in ontario: prevalence and perceptions. J Clin Oncol 2000; 18: 2515-21
43. Oldendick R, Coker AL, Wieland D. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Med J 2000; 93 (4): 375-81
44. Eliason BC, Huebner J, Marchand L. What physicians can learn from consumers of dietary supplements. J Fam Pract 1999; 48: 459-63
45. Kaptchuk TJ, Eisenberg DM. The persuasive appeal of alternative medicine. Ann Intern Med 1998; 129: 1061-5
46. Shapiro DA, Safer M. Integrating complementary therapies into a traditional oncology practice. Oncol Issues 2002; 17 (1): 35-40
47. Gabel JR, Pickreign JF, Whitmore HH, et al. Embraceable you: how employers influence health plan enrollment. Health Aff 2001 Jul/Aug; 20 (4): 196-208
48. Teitelman DL, Lee FC. The Florida blues experience in improving cancer management. Oncol News Int 2002 May; 11 (5): 47-9
49. Kirsch WD, Lee R. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program. Manag Care Interface 1999 Aug; 12: 65-8
50. Costich TD, Lee FC. Improving cancer care in a Kentucky managed care plan: a case study of cancer disease management. Dis Manag 2003; 6 (1): 9-19